Sudden sensorineural hearing loss

Reading File
Finding Sources
Searching PubMed

"sudden sensorineural hearing loss" treatment

Searching Images

sudden sensorineural hearing loss audiogram

This composite diagnostic image illustrates the audiological evaluation of a patient with bilateral sudden sensorineural hearing loss (SSNHL). Panel A displays the admission pure-tone audiograms (PTA) for the right (R) and left (L) ears, showing total hearing loss with thresholds primarily between 80-120 dBHL across frequencies from 125 Hz to 8 kHz. Panel B shows the follow-up audiogram after three months, demonstrating a partial recovery to severe hearing loss, with thresholds improved to the 60-80 dBHL range. Panel C presents electrocochleogram (ECochG) waveforms for both ears at 90 dBnHL. The waveforms clearly identify the summating potential (SP) and action potential (AP) peaks. The SP/AP ratios (0.25 for the right ear and 0.33 for the left ear) are within normal clinical limits, helping to localize the pathology and assess cochlear function. The images provide a longitudinal view of disease progression and recovery, useful for medical education on otolaryngology and neuro-otology cases involving vascular or idiopathic hearing loss.

This composite diagnostic image illustrates the audiological evaluation of a patient with bilateral sudden sensorineural hearing loss (SSNHL). Panel A displays the admission pure-tone audiograms (PTA) for the right (R) and left (L) ears, showing total hearing loss with thresholds primarily between 80-120 dBHL across frequencies from 125 Hz to 8 kHz. Panel B shows the follow-up audiogram after three months, demonstrating a partial recovery to severe hearing loss, with thresholds improved to the 60-80 dBHL range. Panel C presents electrocochleogram (ECochG) waveforms for both ears at 90 dBnHL. The waveforms clearly identify the summating potential (SP) and action potential (AP) peaks. The SP/AP ratios (0.25 for the right ear and 0.33 for the left ear) are within normal clinical limits, helping to localize the pathology and assess cochlear function. The images provide a longitudinal view of disease progression and recovery, useful for medical education on otolaryngology and neuro-otology cases involving vascular or idiopathic hearing loss.

Educational medical composite featuring clinical audiograms and diagnostic MRI images focusing on intralabyrinthine schwannomas. Panel (a) shows a pure-tone audiogram demonstrating a mid-frequency 'cookie-bite' sensorineural hearing loss. Corresponding axial T1-weighted contrast-enhanced MRI (a') reveals a focal, hyperintense enhancing mass within the right cochlea (arrow), consistent with an intracochlear schwannoma. Panel (b) shows an audiogram with low-frequency sensorineural hearing loss. The associated axial T2-weighted MRI (b') identifies a small, hypointense filling defect in the high-signal fluid of the right vestibule (arrow), diagnostic of an intravestibular schwannoma. These images illustrate the correlation between specific inner ear tumor locations and their characteristic audiological presentations. The radiological views highlight the importance of thin-section temporal bone imaging in detecting small intralabyrinthine lesions that may present with symptoms mimicking idiopathic sudden sensorineural hearing loss or Meniere's disease.

Educational medical composite featuring clinical audiograms and diagnostic MRI images focusing on intralabyrinthine schwannomas. Panel (a) shows a pure-tone audiogram demonstrating a mid-frequency 'cookie-bite' sensorineural hearing loss. Corresponding axial T1-weighted contrast-enhanced MRI (a') reveals a focal, hyperintense enhancing mass within the right cochlea (arrow), consistent with an intracochlear schwannoma. Panel (b) shows an audiogram with low-frequency sensorineural hearing loss. The associated axial T2-weighted MRI (b') identifies a small, hypointense filling defect in the high-signal fluid of the right vestibule (arrow), diagnostic of an intravestibular schwannoma. These images illustrate the correlation between specific inner ear tumor locations and their characteristic audiological presentations. The radiological views highlight the importance of thin-section temporal bone imaging in detecting small intralabyrinthine lesions that may present with symptoms mimicking idiopathic sudden sensorineural hearing loss or Meniere's disease.

This diagnostic image displays two comparative pure-tone audiograms representing initial audiology testing for the right (a) and left (b) ears. Each graph plots frequency in Hertz (Hz) on the x-axis, ranging from 125 Hz to 8000 Hz, against hearing level in decibels (dB) on the y-axis, ranging from -10 dB to 120 dB. The audiogram for the right ear (a) demonstrates a severe-to-profound high-frequency sensorineural hearing loss (SNHL), characterized by a sharp downward slope with thresholds exceeding 80-100 dB at higher frequencies. In contrast, the audiogram for the left ear (b) shows hearing thresholds within the normal to mild loss range across most frequencies, illustrating a significant asymmetrical hearing impairment. These clinical visuals are used in Otolaryngology (ENT) to diagnose and monitor auditory dysfunction, specifically identifying the severity and configuration of sensorineural hearing loss often associated with pathology or sudden onset syndromes.

This diagnostic image displays two comparative pure-tone audiograms representing initial audiology testing for the right (a) and left (b) ears. Each graph plots frequency in Hertz (Hz) on the x-axis, ranging from 125 Hz to 8000 Hz, against hearing level in decibels (dB) on the y-axis, ranging from -10 dB to 120 dB. The audiogram for the right ear (a) demonstrates a severe-to-profound high-frequency sensorineural hearing loss (SNHL), characterized by a sharp downward slope with thresholds exceeding 80-100 dB at higher frequencies. In contrast, the audiogram for the left ear (b) shows hearing thresholds within the normal to mild loss range across most frequencies, illustrating a significant asymmetrical hearing impairment. These clinical visuals are used in Otolaryngology (ENT) to diagnose and monitor auditory dysfunction, specifically identifying the severity and configuration of sensorineural hearing loss often associated with pathology or sudden onset syndromes.

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
I now have everything needed for a comprehensive answer.

Sudden Sensorineural Hearing Loss (SSNHL)

Definition

SSNHL is defined as a decrease in hearing of ≥30 dB at 3 contiguous audiometric frequencies occurring within a 72-hour period (NIDCD / AAO-HNS 2012 guideline). It is best understood as a syndrome, not a diagnosis - the loss may result from many underlying causes, most of which remain idiopathic after workup.
  • Cummings Otolaryngology Head and Neck Surgery

Epidemiology

FeatureDetail
Incidence5-20 per 100,000 persons/year
Peak age6th decade
SexM = F
LateralityAlmost always unilateral; simultaneous bilateral is very rare
Share of ENT outpatient visits~2-3%

Etiology

Over 100 etiologies have been proposed. The main categories are:

Infectious

  • Viral (most commonly implicated): mumps, measles, herpes zoster oticus, HSV, VZV, CMV, HIV, EBV, influenza, parainfluenza, Lassa fever, Zika, West Nile virus
    • 28% of patients report a viral URTI within 1 month before onset
    • Mumps virus has been directly isolated from perilymph of SSNHL patients
  • Bacterial: syphilis (important and treatable), Lyme disease, mycoplasma, meningitis (Streptococcal, cryptococcal)

Neoplastic

  • Vestibular schwannoma (acoustic neuroma): ~1% of SSNHL presentations - this is the key "must not miss" diagnosis
  • Meningioma, epidermoid, hemangioma, temporal bone metastases, lymphoma, leukemia

Traumatic

  • Temporal bone fracture, acoustic trauma, inner ear concussion, perilymphatic fistula, barotrauma

Ototoxic

  • Aminoglycosides, loop diuretics, cisplatin, quinine, aspirin (high dose)

Immunologic/Autoimmune

  • Autoimmune inner ear disease (AIED), Cogan syndrome, polyarteritis nodosa, SLE, Wegener granulomatosis

Vascular

  • Labyrinthine artery occlusion, hypercoagulable states, polycythemia, leukemia, macroglobulinemia

Other / Idiopathic

  • The majority of cases remain idiopathic after thorough evaluation
  • Principal pathogenetic theories for idiopathic cases:
    1. Viral cochleitis/neuritis
    2. Vascular occlusion of the labyrinthine artery
    3. Intracochlear membrane breaks
    4. Autoimmune damage

Clinical Presentation

  • Most common: unilateral hearing loss noticed on awakening (patient woke up deaf in one ear)
  • Progressive loss over hours to days
  • Aural fullness - very common, sometimes the only complaint
  • Tinnitus - variable; may precede hearing loss
  • Vertigo/dysequilibrium - present in ~40% of patients; a poor prognostic sign

Diagnosis

Pure-Tone Audiogram

This is the cornerstone investigation confirming SNHL pattern and severity.
SSNHL audiogram showing bilateral severe-to-profound SNHL at admission (Panel A, 80-120 dBHL) with partial recovery to 60-80 dBHL at 3 months (Panel B), alongside electrocochleogram waveforms
Audiogram of bilateral SSNHL: Panel A (admission) shows near-total loss at 80-120 dBHL; Panel B (3-month follow-up) shows partial recovery to 60-80 dBHL. Panel C shows ECochG with SP/AP ratios within normal limits.

Investigations

InvestigationPurpose
MRI internal auditory canals with gadoliniumExclude acoustic neuroma / other retrocochlear lesion (mandatory - 1% of acoustic neuromas present as SSNHL)
Pure-tone audiometry + speech audiometryConfirm and characterize loss
TympanometryRule out middle ear pathology
Blood testsCBC, ESR, CRP, ANA, FTA-ABS (syphilis serology), lipids, coagulation studies, blood glucose
FTA-ABS / VDRLSyphilis - treatable cause
Lyme serologyIn endemic areas
Note: Routine screening blood tests have low yield unless the history suggests a specific cause. MRI is the high-priority investigation. - Bailey and Love's Short Practice of Surgery 28th Edition

Prognosis

Without any treatment, 30-65% of patients experience complete or partial spontaneous recovery. Four variables predict prognosis:
  1. Severity of loss - more severe = worse prognosis; profound losses have exceptionally poor prognosis
  2. Audiogram shape - upsloping and mid-frequency losses recover better; downsloping and flat losses do worse
  3. Presence of vertigo - poor prognostic indicator, especially with downsloping loss
  4. Age - older age associated with worse outcomes

Management

First-Line: Systemic (Oral) Corticosteroids

Prednisone 60 mg/day (or 1 mg/kg/day) for 10-14 days, followed by gradual taper. Oral steroids given within the first 2 weeks show recovery rates up to 80% (vs. 30-65% spontaneous). This is the treatment of choice.
  • Cummings Otolaryngology

Intratympanic (IT) Steroids

Two roles:
  1. Primary treatment: randomized controlled data shows no significant difference vs. oral steroids - reinforces oral route as first-line
  2. Salvage therapy: for patients who fail oral steroids - multiple retrospective and prospective studies show audiometric improvement. Key principle: IT salvage should be used as soon as it is clear oral steroids are not working, preferably within the first 2 weeks of the original insult. The longer the delay, the worse the salvage outcome.
Dosing:
  • Dexamethasone: 1-25 mg/mL; or methylprednisolone 62.5 mg/mL
  • Volume: 0.3-0.5 mL to fill the middle ear space
  • Route: direct IT injection or through tympanostomy tube

Other Treatments (Limited/Investigational)

  • Hyperbaric oxygen therapy (HBO): used as adjunct in some centers; a 2026 systematic review (PMID 40747804) examined the evidence - benefit remains debated, especially when added to steroids
  • Vasodilators / rheological agents (carbogen, histamine, dextran, pentoxifylline): used in some European centers; evidence quality is low
  • Antiviral therapy: acyclovir - no robust evidence supporting routine use for idiopathic cases
  • Anticoagulants: no proven benefit in idiopathic SSNHL

Treat Identified Causes

  • Syphilis → IV penicillin
  • Lyme disease → doxycycline or IV ceftriaxone
  • Autoimmune inner ear disease → prolonged immunosuppression

Rehabilitation

  • Patients with residual loss: hearing aids, or cochlear implant evaluation for profound losses
  • Contralateral CROS/BiCROS hearing aids for single-sided deafness

Summary Flowchart

Sudden hearing loss (≥30 dB, 3 frequencies, ≤72 hrs)
        ↓
Confirm SNHL on audiogram (rule out CHL with tuning forks / tympanometry)
        ↓
Treat as otologic emergency — start oral prednisone ASAP
        ↓
Urgent MRI IAC + gadolinium (exclude acoustic neuroma)
        ↓
Targeted bloodwork (FTA-ABS, CBC, ESR, ANA, glucose, lipids)
        ↓
No improvement after 2 weeks?
        ↓
Intratympanic steroid salvage (within 2 weeks of onset)
        ↓
Audiology follow-up; consider HBO, hearing rehabilitation

Recent Evidence (2024-2026)

A 2024 practice guideline for diagnosis and management of acute SNHL and a 2024 meta-analysis on natural history of untreated ISSNHL (PMID 38808803) have reinforced conservative spontaneous recovery rates and the importance of early steroid treatment. A 2026 meta-analysis on hyperbaric oxygen (PMID 40747804) examined its role as adjunct therapy - outcomes are favorable when HBO is combined with steroids but data quality remains heterogeneous.

Key take-home points:
  • SSNHL is an otologic emergency - treat promptly with oral steroids (prednisone 1 mg/kg/day)
  • MRI IAC with gadolinium is mandatory to exclude retrocochlear pathology (acoustic neuroma)
  • Intratympanic steroids are valuable salvage if oral steroids fail - use within 2 weeks
  • Spontaneous recovery occurs in 30-65% without treatment, so all recovery rates must be interpreted against this background rate
This is a shared conversation. Sign in to Orris to start your own chat.